| Wainzua 45 mg solution for injection in pre-filled pen EU/1/24/1875/001 |
Eplontersen sodium |
AstraZeneca AB |
— |
| Wakix 18 mg film-coated tablets EU/1/15/1068/002 |
Pitolisant hydrochloride |
Bioprojet Pharma |
— |
| Wakix 4.5 mg film-coated tablets EU/1/15/1068/001 |
Pitolisant hydrochloride |
Bioprojet Pharma |
— |
| Warfant 1 mg Tablets PA0073/139/001 |
WARFARIN SODIUM |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Warfant 3 mg Tablets PA0073/139/002 |
WARFARIN SODIUM |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Warfant 5 mg Tablets PA0073/139/003 |
WARFARIN SODIUM |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Warfarin Teva 0.5 mg tablets PA2050/001/001 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 1 mg tablets PA2050/001/002 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 10 mg tablets PA2050/001/009 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 2 mg tablets PA2050/001/003 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 2.5 mg tablets PA2050/001/004 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 3 mg tablets PA2050/001/005 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 5 mg tablets PA2050/001/006 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 6 mg tablets PA2050/001/007 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 7.5 mg tablets PA2050/001/008 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warticon 0.15% w/w Cream PA1113/017/001 |
Podophyllotoxin |
Phoenix Labs |
Marketed |
| Water for Injections Ph Eur PA1122/001/001 |
Water for injections |
Noridem Enterprises Limited |
Marketed |
| Water for Injections Ph. Eur PA0179/009/003 |
Water for injections |
B. Braun Medical Limited, |
Marketed |
| Water for Injections Ph. Eur., viaflo container PA2299/013/001 |
Water for injection |
Baxter Holding B.V. |
Marketed |
| Water for injections, solvent for parenteral use PA2059/035/001 |
Water for injections |
Fresenius Kabi Deutschland GmbH |
Marketed |
| WAXSOL 0.5% w/v Ear Drops Solution PA25506/010/001 |
Docusate sodium |
Cooper Consumer Health B.V. |
Marketed |
| Waylivra 285 mg Solution for injection EU/1/19/1360/001-002 |
VOLANESORSEN SODIUM |
Akcea Therapeutics Ireland Ltd |
— |
| WAYRILZ 400 mg film-coated tablets EU/1/25/1974/001-003 |
Rilzabrutinib |
Sanofi B.V. |
— |
| Wegovy 0.25 mg Solution for injection EU/1/21/1608/001 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 0.25 mg Solution for injection EU/1/21/1608/006 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 0.5 mg Solution for injection EU/1/21/1608/002 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 0.5 mg Solution for injection EU/1/21/1608/007/012 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1 mg Solution for injection EU/1/21/1608/003 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1 mg Solution for injection EU/1/21/1608/008 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1.7 mg Solution for injection EU/1/21/1608/004 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1.7 mg Solution for injection EU/1/21/1608/009 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 2.4 mg Solution for injection EU/1/21/1608/005 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 2.4 mg Solution for injection EU/1/21/1608/010-011 |
Semaglutide |
Novo Nordisk A/S |
— |
| WELIREG 40 mg film-coated tablets EU/1/24/1893/001-002 |
Belzutifan |
Merck Sharp & Dohme BV, |
— |
| WEZENLA 130 mg Concentrate for solution for infusion EU/1/24/1823/004 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 45 mg Solution for injection EU/1/24/1823/001 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 45 mg Solution for injection pre-filled syringe EU/1/24/1823/002 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 90 mg Solution for injection pre-filled syringe EU/1/24/1823/003 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| Whitfield's Antifungal 3% w/w & 6% w/w Ointment PA0206/024/001 |
Salicylic acid, Benzoic acid |
Ovelle Limited |
Marketed |
| Wilate, 1000 IU VWF/1000 IU FVIII, powder and solvent for solution for injection PA2219/008/002 |
Human factor viii, Von willebrand factor human |
Octapharma (IP) |
Marketed |
| Wilate, 500 IU VWF/500 IU FVIII, powder and solvent for solution for injection PA2219/008/001 |
Human factor viii, Von willebrand factor human |
Octapharma (IP) |
Marketed |
| WILZIN EU/1/04/286/1-2 |
Zinc acetate dihydrate |
Recordati Rare Diseases |
— |
| Winlevi 10 mg/g cream EU/1/25/1927/001-003 |
Clascoterone |
Cassiopea S.p.A. |
— |
| Winrevair 45 mg powder and solvent for solution for injection EU/1/24/1850/001-002 |
Sotatercept |
Merck Sharp & Dohme BV, |
— |
| Winrevair 60 mg powder and solvent for solution for injection EU/1/24/1850/003-004 |
Sotatercept |
Merck Sharp & Dohme BV, |
— |
| Wynzora 50 micrograms/g + 0.5 mg/g cream PA0968/006/001 |
Calcipotriol, Betamethasone |
Almirall, S.A. |
Not marketed |
| Wyost 120 mg solution for injection EU/1/24/1812/001 |
Denosumab |
Sandoz GmbH |
— |